MLL
Moody Lynn & Lieberson’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,353
| Closed | -$1.15M | – | 253 |
|
|
2024
Q4 | $1.15M | Sell |
13,353
-400
| -3% | -$34.4K | 0.07% | 107 |
|
|
2024
Q3 | $1.64M | Sell |
13,753
-51,287
| -79% | -$6.11M | 0.1% | 98 |
|
|
2024
Q2 | $9.28M | Buy |
65,040
+100
| +0.2% | +$14.3K | 0.61% | 38 |
|
|
2024
Q1 | $8.34M | Sell |
64,940
-360
| -0.6% | -$46.2K | 0.56% | 39 |
|
|
2023
Q4 | $6.76M | Sell |
65,300
-20
| -0% | -$2.07K | 0.51% | 44 |
|
|
2023
Q3 | $5.94M | Buy |
65,320
+29,635
| +83% | +$2.7M | 0.51% | 44 |
|
|
2023
Q2 | $5.77M | Sell |
35,685
-780
| -2% | -$126K | 0.47% | 50 |
|
|
2023
Q1 | $5.8M | Sell |
36,465
-25
| -0.1% | -$3.98K | 0.52% | 47 |
|
|
2022
Q4 | $4.94M | Buy |
+36,490
| New | +$4.94M | 0.45% | 46 |
|
|
2016
Q3 | – | Sell |
-4,400
| Closed | -$237K | – | 178 |
|
|
2016
Q2 | $237K | Hold |
4,400
| – | – | 0.04% | 145 |
|
|
2016
Q1 | $238K | Hold |
4,400
| – | – | 0.04% | 150 |
|
|
2015
Q4 | $256K | Sell |
4,400
-73,800
| -94% | -$4.29M | 0.04% | 156 |
|
|
2015
Q3 | $4.24M | Buy |
78,200
+73,800
| +1,677% | +$4M | 0.81% | 49 |
|
|
2015
Q2 | $241K | Hold |
4,400
| – | – | 0.04% | 172 |
|
|
2015
Q1 | $235K | Buy |
+4,400
| New | +$235K | 0.04% | 170 |
|
|
2014
Q4 | – | Sell |
-4,400
| Closed | -$210K | – | 201 |
|
|
2014
Q3 | $210K | Sell |
4,400
-245
| -5% | -$11.7K | 0.03% | 180 |
|
|
2014
Q2 | $215K | Hold |
4,645
| – | – | 0.03% | 187 |
|
|
2014
Q1 | $212K | Buy |
+4,645
| New | +$212K | 0.03% | 186 |
|
|
2013
Q4 | – | Sell |
-4,860
| Closed | -$822K | – | 203 |
|
|
2013
Q3 | $822K | Buy |
4,860
+3,530
| +265% | +$597K | 0.13% | 114 |
|
|
2013
Q2 | $206K | Buy |
+1,330
| New | +$206K | 0.04% | 155 |
|